| 1 |
Etudes de cas d'entreprises pharmaceutiques (en anglais) |
2007/2012 |
Université de Lilles |
Wilex 2011, UCB 2011 & 2012, Thrombogenics 1 & 2, Teva 2008 & 2012, Serono 2007, Patheon 2009, 2010 & 2011, Novo Nordisk 2009, Nitromed 2008, Nicox 2009, Nektar 2010, Morphosys 2011, Monogram 2009, Medivir 2012, Jazz pharmaceuticals 2010, Ipsen 2007, 2009, 2010 & 2012, Intercell 2011, Innate pharma 2011, Gilead 2008, Genfit 2009, Galapagos 2011, Elan corporation 2010, Dendreon 2011, Crucel 2009 1 & 2, Covance 2011, Combinatorx 2007, Celgene 2011, Celera 2007, Biomérieux 2010, Biogen-idec 2008, Bioalliance 2011, Bayer Schering Pharma 2010, Bayer 2011, Amylin 2008, Addex pharmaceutical 2009, Actelion 2007 & 2009/1 & 2, Ablynx 2011 & 2012, Modèles industriels 2010. |
